AMP’s financial planning unit was hit Wednesday with an enforcement action by the corporate regulator alleging its planners generated extra commissions by replacing, rather than transferring, life insurance policies for existing clients.
International airline Air New Zealand has been hit with a $15 million penalty for participating in a global air cargo cartel to fix the price of fuel, insurance and security surcharges.
The Full Federal Court has upheld most of a ruling that found LG did not engage in misleading or deceptive conduct by failing to inform purchasers of faulty televisions of the remedies available to them under the Australian Consumer Law.
Herbert Smith Freehills has prevailed in a suit by United Petroleum alleging the law firm and former United chairman Martin Hudson breached their duties to the company when they pulled a planned initial public offering in 2016.
Optus can hang on to its Optus trade mark for marketing and advertising services, after successfully challenging a ruling that the mark should be deregistered for non-use in those areas.
The Australian Competition and Consumer Commission has brought an unprecedented court action against Australia’s largest potato wholesaler Mitolo Group, as it continues to ramp up enforcement over unfair contract terms.
Regulating third-party litigation funders gets a resounding yes, but experts are divided on removing the ban on contingency fees and other recommendations for reforming the class action regime. Lawyerly spoke to defence and plaintiff-side lawyers, as well as funders, for their take on the recent proposals, and five major talking points emerged.
After a marathon hearing in court on Monday, law firm Squire Patton Boggs lost its battle to avoid client communication restraints that other parties in the GetSwift class action saga voluntarily agreed to.
Online bookrunner Crownbet has been sued by rival Sportsbet over its attempt to trade mark and operate under the “Sportingbet” name.
The Australian Competition and Consumer Commission is seeking special leave from the High Court to appeal a ruling in a case alleging drug giant Pfizer misused its market power ahead of the expiration of its patent for Lipitor.